文献速递胸部肿瘤放疗放疗物理与技术

食管周向剂量-长度直方图参数预测胸部放疗患者吞咽困难

Esophageal Circumferential Dose-Length Histogram Parameters to Predict Dysphagia in Patients Receiving Thoracic Radiation Therapy: A Single-Institution Experience.
PubMed 文献 · Adv Radiat Oncol · 2025-05-24

本研究回顾性分析2019至2023年接受根治性胸部放疗的107例患者,评估食管剂量-长度直方图(DLH)参数与剂量-体积直方图(DVH)参数对吞咽困难的预测价值。结果显示,部分周向或全周向食管照射长度参数(LP55、LP60、LF60)与患者报告的吞咽困难相关,而与临床医生报告的CTCAE≥2级吞咽困难无关。

要点

  • 食管部分周向接受≥55 Gy或≥60 Gy的长度(LP55、LP60)每增加0.5 cm,患者报告吞咽困难风险分别增加8%和9%。
  • 食管全周向接受≥60 Gy的长度(LF60)每增加0.5 cm,患者报告吞咽困难风险增加11%。
  • DLH参数与DVH参数互补,但均未预测临床医生报告的CTCAE≥2级吞咽困难。

核心结论

  • 食管DLH参数(LP55、LP60、LF60)与患者报告的吞咽困难相关,可补充传统DVH参数。

研究设计与样本

  • 单中心回顾性研究,纳入2019至2023年接受根治性胸部放疗的107例患者,收集前瞻性记录的临床医生报告(CTCAE v.4)和患者报告(PRO-CTCAE v.1)的吞咽困难。

主要发现

  • 患者报告和医生报告的≥2级吞咽困难发生率分别为15.9%(17例)和5.6%(6例),差异有统计学意义(P = .0015)。
  • LP55和LP60每增加0.5 cm,患者报告吞咽困难风险分别增加8%和9%;LF60每增加0.5 cm,风险增加11%。
  • LP55和LP60与食管V60体积参数强相关(ρ = 0.751和0.729)。
  • 未发现DVH或DLH参数预测CTCAE≥2级吞咽困难。

关键数值与推荐

  • 食管部分周向照射长度(LPdose)定义为食管≥50%周向暴露于阈值剂量的长度,全周向照射长度(LFdose)定义为≥90%周向暴露的长度。

临床怎么用

  • 在胸部放疗计划评估中,可考虑使用食管DLH参数(如LP55、LP60、LF60)辅助预测患者报告的吞咽困难,以补充DVH参数。

局限性

  • 单中心回顾性研究,样本量有限,结果需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Chemoradiation for locally advanced non-small cell lung cancer can cause severe esophagitis. Techniques to spare the contralateral esophagus may mitigate toxicity, but traditional dose-volume histograms (DVH) do not capture the degree of circumferential irradiation. We evaluated dose-length histogram (DLH) parameters as predictors of dysphagia compared with DVH metrics. METHODS: We retrospectively reviewed patients treated with definitive thoracic radiation therapy from 2019 to 2023. Descriptive statistics described the cohort. Clinician-reported (National Cancer Institute Common Terminology Criteria for Adverse Events [CTCAE] v.4) and patient-reported outcomes (PRO)-CTCAE v.1 dysphagia within 120 days of treatment start were collected prospectively. The McNemar test compared dichotomized scores. The length of esophageal full-circumferential (LFdose) and partial-circumferential irradiation (LPdose) was defined as the length of the esophagus with ≥90% and ≥50% circumference exposure to threshold radiation doses, respectively. Spearman correlation examined relationships between LFdose, LPdose, and volumetric (Vdose) parameters. Associations between LFdose, LPdose, and Vdose, and grade ≥2 dysphagia were evaluated using univariate logistic regression. Likelihood ratio tests assessed model fit. RESULTS: Of 107 patients, 86.9% (93) had non-small cell lung cancer, all received ≥60 Gy (median, 63 Gy; range, 60-70 Gy), and 94.4% (101) received concurrent chemotherapy. Patients and physicians reported rates of grade ≥2 dysphagia differently: 17 (15.9%) and 6 (5.6%), respectively (P = .0015). Each 0.5 cm increase in the length of partial-circumference esophagus receiving ≥55 Gy (LP55) and 60 Gy (LP60) resulted in increased odds of PRO-CTCAE dysphagia by 8% and 9%, respectively. Each 0.5 cm increase in full-circumference esophagus receiving ≥60 Gy (LF60) resulted in 11% increased odds of PRO-CTCAE dysphagia. Esophageal DLH parameters, LP55 and LP60, correlated with the esophageal V60 volumetric parameter strongly (ρ = 0.751 and 0.729, respectively). No DVH or DLH parameter predicted grade ≥2 CTCAE dysphagia. CONCLUSION: Esophageal DLH metrics assessing partial- or full-circumferential esophageal irradiation, specifically LP55, LP60, and LF60, are associated with patient-reported dysphagia and complement traditional DVH parameters.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Brown A, Hu C, Ke S, et al. Esophageal Circumferential Dose-Length Histogram Parameters to Predict Dysphagia in Patients Receiving Thoracic Radiation Therapy: A Single-Institution Experience. Adv Radiat Oncol. 2025. PMID: 40611876. doi:10.1016/j.adro.2025.101807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。